Anti-amyloid monoclonal antibodies for Alzheimer's disease are now shifting clinical focus from diagnosis to individual treatment optimisation. Amyloid PET imaging may enable healthcare systems to establish baseline measurements and guide decisions on therapy continuation, switching, or discontinuation. — Czech Republic Delegation Visits LRMC (9399372).jpg by Travis Jones / Public domain via Wikimedia Commons (Public domain)
MD, MPH, PhD. Editor-in-Chief, Georgian Medical Journal (GMJ). Professor and Head, School of Public Health, David Tvildiani Medical University (DTMU), Tbilisi, Georgia. Chair, Public Health Institute of Georgia (PHIG). President, Accréditation Sans Frontières (ASF), Paris. Secretary/Treasurer, UEMS Section of Public Health. WHO Consultant, Health and Migration, Geneva. Former Member, UN Secretary-General's Independent Accountability Panel for Every Woman, Every Child, Every Adolescent (IAP-EWEC, 2016–2021). ORCID: 0000-0001-7609-4515.
